Viscerotropic Disease: Case Definition and Guidelines for Collection, Analysis, and Presentation of Immunization Safety Data

Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile J, Newport M . Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med. 1996; 335(26):1956-61. DOI: 10.1056/NEJM199612263352604. View

. Yellow fever surveillance and outbreak response: revision of case definitions, October 2010. Wkly Epidemiol Rec. 2010; 85(47):465-72. View

Pulendran B, Miller J, Querec T, Akondy R, Moseley N, Laur O . Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis. 2008; 198(4):500-7. PMC: 3734802. DOI: 10.1086/590187. View

Mazza Nascimento M, Riella M . Raising awareness of chronic kidney disease in a Brazilian urban population. Braz J Med Biol Res. 2009; 42(8):750-5. DOI: 10.1590/s0100-879x2009000800010. View

Monath T . Yellow fever: an update. Lancet Infect Dis. 2002; 1(1):11-20. DOI: 10.1016/S1473-3099(01)00016-0. View

Chan R, Penney D, Little D, Carter I, Roberts J, Rawlinson W . Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet. 2001; 358(9276):121-2. DOI: 10.1016/S0140-6736(01)05341-7. View

Des Jarlais D, Lyles C, Crepaz N . Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004; 94(3):361-6. PMC: 1448256. DOI: 10.2105/ajph.94.3.361. View

Warren J, Blumbergs P, Thompson P . Rhabdomyolysis: a review. Muscle Nerve. 2002; 25(3):332-47. DOI: 10.1002/mus.10053. View

Wheelock E, Sibley W . CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS. N Engl J Med. 1965; 273:194-8. DOI: 10.1056/NEJM196507222730404. View

10.

P Monath T, Liu J, Kanesa-Thasan N, Myers G, Nichols R, Deary A . A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A. 2006; 103(17):6694-9. PMC: 1436023. DOI: 10.1073/pnas.0601932103. View

11.

Belsher J, Gay P, Brinton M, DellaValla J, Ridenour R, Lanciotti R . Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine. 2007; 25(50):8480-5. PMC: 7115366. DOI: 10.1016/j.vaccine.2007.08.061. View

12.

. Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002. MMWR Morb Mortal Wkly Rep. 2002; 51(44):989-93. View

13.

Staples J, Gershman M, Fischer M . Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010; 59(RR-7):1-27. View

14.

King C, Keating C, Muruka J, Ouma J, Houser H, Siongok T . Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg. 1988; 39(4):361-8. DOI: 10.4269/ajtmh.1988.39.361. View

15.

Adhiyaman V, Oke A, Cefai C . Effects of yellow fever vaccination. Lancet. 2001; 358(9296):1907-8. DOI: 10.1016/S0140-6736(01)06914-8. View

16.

Eidex R . History of thymoma and yellow fever vaccination. Lancet. 2004; 364(9438):936. DOI: 10.1016/S0140-6736(04)17017-7. View

17.

Benichou C, Solal Celigny P . Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol (1978). 1991; 33(3):257-62. View

18.

P Monath T, McCarthy K, Bedford P, Johnson C, Nichols R, Yoksan S . Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 2002; 20(7-8):1004-18. DOI: 10.1016/s0264-410x(01)00457-1. View

19.

Sauret J, Marinides G, Wang G . Rhabdomyolysis. Am Fam Physician. 2002; 65(5):907-12. View

20.

Schrauder A, Henke-Gendo C, Seidemann K, Sasse M, Cario G, Moericke A . Varicella vaccination in a child with acute lymphoblastic leukaemia. Lancet. 2007; 369(9568):1232. DOI: 10.1016/S0140-6736(07)60567-4. View